This new offering is expected to significantly reduce the time required to conduct protein ligand docking studies. Structure based drug design approach has traditionally been affected by limitations due to either slow or inaccurate docking activity. Researchers rarely could access a solution that was fast while being accurate. With the combination of V Life’s innovative GRIP technology and the computational power of CRL’s supercomputer “eka”, researchers can now easily access a one stop solution to improve productivity from their structure based design efforts. With this joint offering, V Life and CRL have reinforced their commitment to address the scientific and technological challenges in the computational discovery domain on the basis of their core strengths.

Dr. Vipin Chaudhary, CEO, CRL, commented CRL makes very high-end computing available to industries in India and abroad using an on-demand HPC cloud platform. We are delighted to tie up with VLife to bring to scientists the combined power of a high performance computational cluster and a smart and accurate docking technology. We are confident that this combination will offer a long-term competitive advantage to customers using the structure based design approach for discovery research in a variety of industries.